Profile
Mark L.
Levitt is currently Director at EnGeneIC Pty Ltd. and Chief Scientific Officer at RedHill Biopharma Ltd. since 2017.
Formerly, Dr. Levitt was Director at UPMC Cancer Institute and Head of the Lung Cancer Unit at Sheba Medical Center.
Mark Levitt active positions
| Companies | Position | Start |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Director/Board Member | - |
Former positions of Mark Levitt
| Companies | Position | End |
|---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Director/Board Member | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Health Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
- Stock Market
- Insiders
- Mark Levitt
















